AU Patent

AU2021369683A1 — Sulcus implants and methods of using the same

Assigned to University of Colorado Colorado Springs · Expires 2023-04-27 · 3y expired

What this patent protects

This disclosure provides ophthalmic implants such as sulcus implants which can comprise one or more drug delivery devices. Further provided herein are methods of using the drug delivery ophthalmic devices described herein for implantation into a subject's eye, e.g., into an eye's…

USPTO Abstract

This disclosure provides ophthalmic implants such as sulcus implants which can comprise one or more drug delivery devices. Further provided herein are methods of using the drug delivery ophthalmic devices described herein for implantation into a subject's eye, e.g., into an eye's ciliary sulcus or capsular bag. The implant comprises: a ring or partial ring comprising a first material and configured for implantation into an eye of a subject, the ring or partial ring characterized by an outer circumferential surface, an inner wall, and a central aperture; and a closed loop haptic comprising a second material and attached to the ring or partial ring at a haptic first end and at a haptic second end wherein the first material and the second material have different chemical compositions and the ring or partial ring is more rigid than the closed loop haptic.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021369683A1
Jurisdiction
AU
Classification
Expires
2023-04-27
Drug substance claim
No
Drug product claim
No
Assignee
University of Colorado Colorado Springs
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.